<?xml version="1.0" encoding="UTF-8"?>
<ref id="B31-vaccines-08-00174">
 <label>31.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dayan</surname>
    <given-names>G.H.</given-names>
   </name>
   <name>
    <surname>Galán-Herrera</surname>
    <given-names>J.-F.</given-names>
   </name>
   <name>
    <surname>Forrat</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Zambrano</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Bouckenooghe</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Harenberg</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Guy</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Lang</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico</article-title>
  <source>Hum. Vaccines Immunother.</source>
  <year>2014</year>
  <volume>10</volume>
  <fpage>2853</fpage>
  <lpage>2863</lpage>
  <pub-id pub-id-type="doi">10.4161/21645515.2014.972131</pub-id>
  <?supplied-pmid 25483647?>
  <pub-id pub-id-type="pmid">25483647</pub-id>
 </element-citation>
</ref>
